Management cares about only one thing. Paperwork. They will forgive almost anything else - cost overruns, gross incompetence, criminal indictments - as long as the paperwork's filled out properly. And in on time.”? Connie Willis, Bellwether
Today, we take a look at a small biopharma concern just up the road from me here in Miami. The company had three products approved by the FDA in 2018 and is in the early stages of commercialization. We dive into this interesting small-cap concern and 'Busted IPO' in the paragraphs below.
Company Overview:
TherapeuticsMD (TXMD)